MedImmune Inc., Japan Tobacco, Kyowa Hakko Kogyo Ltd. deal

By WIR Staff | Jan 1, 2007 | 8:00 AM GMT

Japan Tobacco granted MEDI exclusive worldwide rights, excluding Japan, to develop and commercialize a MAb against inducible-costimulator

Read the full 177 word article

How to gain access

Continue reading with a
two-week free trial.